Welltok®, Inc., the pioneer in health optimization, today announced the acquisition of Seattle-based Mindbloom, an innovative mobile health company. The acquisition will expand Welltok’s capabilities to deliver engaging, interactive mobile experiences through its CaféWell Health Optimization Platform, and allow consumers anytime, anywhere access to compelling health programs, content, applications and communities.
“To profoundly change consumers’ health-related awareness, actions and behaviors for the better, we need an effective and practical platform to become engrained in their daily lives,” said Jeff Margolis, chairman and CEO of Welltok. “We were impressed by the Mindbloom team’s ability to integrate behavioral science and user-centered design principles with health-related content to deliver a superior consumer experience.”
Mindbloom has built popular, top-rated apps, including Bloom for inspiration and Life Game for life improvement. The company has garnered a highly engaged user base and has had apps featured in the Apple App Store℠ and by ABC News. Additionally, leading health plans and pharmacy retailers have collaborated with Mindbloom to create solutions for millions of consumers.
Welltok is revolutionizing the way population health managers align consumer actions and behaviors with the right incentives and rewards. The company recently raised $22.1 million in Series C funding led by New Enterprise Associates (NEA), which included the first investment from the IBM Watson Group and participation from Qualcomm Incorporated, through its venture capital arm, Qualcomm Ventures. The new capital is being used to accelerate product development of CaféWell Concierge powered by IBM Watson and expand the CaféWell Connect partner program, as well as integrate Mindbloom’s capabilities into the CaféWell platform.
“Adding a Pacific Northwest team also allows us to tap into the rich mobile, e-commerce and gaming expertise in the region,” said Margolis. “With Mindbloom on board, we are further strengthening our consumer DNA to help individuals optimize their health.”
March 20, 2014